ArticleCancer2025

Efficacy and safety of pembrolizumab in patients with advanced urothelial carcinoma deemed potentially ineligible for platinum-containing chemotherapy: Post hoc analysis of KEYNOTE-052 and LEAP-011.

Peter H O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.